- Home
- OBIO vs TZOO Comparison
OBIO vs TZOO Comparison
Compare OBIO & TZOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OBIO
- TZOO
- Stock Information
- Founded
- OBIO 2017
- TZOO 1998
- Country
- OBIO United States
- TZOO United States
- Employees
- OBIO N/A
- TZOO N/A
- Industry
- OBIO Medicinal Chemicals and Botanical Products
- TZOO Advertising
- Sector
- OBIO Health Care
- TZOO Consumer Discretionary
- Exchange
- OBIO Nasdaq
- TZOO Nasdaq
- Market Cap
- OBIO 200.1M
- TZOO 224.8M
- IPO Year
- OBIO N/A
- TZOO 2002
- Fundamental
- Price
- OBIO $4.88
- TZOO $21.70
- Analyst Decision
- OBIO Strong Buy
- TZOO Strong Buy
- Analyst Count
- OBIO 4
- TZOO 3
- Target Price
- OBIO $15.75
- TZOO $25.00
- AVG Volume (30 Days)
- OBIO 53.8K
- TZOO 102.8K
- Earning Date
- OBIO 11-12-2024
- TZOO 10-23-2024
- Dividend Yield
- OBIO N/A
- TZOO N/A
- EPS Growth
- OBIO N/A
- TZOO 38.38
- EPS
- OBIO N/A
- TZOO 1.06
- Revenue
- OBIO $2,647,000.00
- TZOO $84,373,000.00
- Revenue This Year
- OBIO $12.39
- TZOO $3.00
- Revenue Next Year
- OBIO $120.99
- TZOO $14.48
- P/E Ratio
- OBIO N/A
- TZOO $20.11
- Revenue Growth
- OBIO N/A
- TZOO 2.97
- 52 Week Low
- OBIO $4.22
- TZOO $7.12
- 52 Week High
- OBIO $10.46
- TZOO $21.19
- Technical
- Relative Strength Index (RSI)
- OBIO 43.91
- TZOO 67.81
- Support Level
- OBIO $4.78
- TZOO $18.86
- Resistance Level
- OBIO $5.84
- TZOO $19.75
- Average True Range (ATR)
- OBIO 0.42
- TZOO 0.90
- MACD
- OBIO -0.04
- TZOO -0.00
- Stochastic Oscillator
- OBIO 24.24
- TZOO 84.33
About OBIO Orchestra BioMed Holdings Inc.
Orchestra BioMed Holdings Inc is a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships. Its partnership-enabled business model focuses on forging strategic collaborations with medical device companies to drive the global commercialization of the products it develops. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension and Virtue Sirolimus AngioInfusionBalloon (SAB) for the treatment of atherosclerotic artery disease.
About TZOO Travelzoo
Travelzoo acts as a publisher of travel and entertainment offers. It operates in four segments. Travelzoo North America segment consists of operations in Canada and the U.S.; Travelzoo Europe segment consists of operations in France, Germany, Spain, and the U.K.; and Jack's Flight Club segment consists of subscription revenue from premium members to access and receive flight deals from Jack's Flight Club via email or via Android or Apple mobile applications; New Initiatives consists of Travelzoo's licensing activities in Asia Pacific territories. It derives its revenue through advertising fees including listing fees paid by travel, entertainment, and local businesses to advertise their offers on the company's media properties. Most of the company's revenue is derived from North America.